WORTHINGTON ENTERPRISES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data WORTHINGTON ENTERPRISES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	3,014	3,582	3,760	3,059	3,171	5,242	4,916	1,246	1,154	1,381
Cost of revenue	2,478	3,019	3,280	2,616	2,532	982	1,095	961	835	1,003
Gross profit	536	563	480	443	639	328	324	285	319	378
Selling, general and administrative	316	367	338	328	351	281	287	283	268	295
Operating income	213	142	145	22.5	167	48.8	29.8	-73.5	-10.7	76.2
Interest expense	29.8	38.7	38.1	31.6	30.3	23.9	18.3	1.59	2.09	6.25
Other non-operating income					2.16	1.85	-4.5	-17.1	-3.22	-3.24
Pre-tax income	297	209	206	111	918	211	160	74	129	201
Income tax	79.2	8.22	43.2	26.3	176	52.7	34.5	39	33.8	46.3
Income from continuing operations						158	126	35.2	96.1	156
Net income to minority interests	13.4	6.06	9.82	5.65	17.7	19.9	12.6	7.2	-1.08	-1.05
Net income	205	195	153	78.8	724	379	257	111	96.1	156
EBITDA	300	245	240	115	255	148	143	7.25	37.5	133
EPS, basic	3.28	3.20	2.68	1.43	13.73	7.60	5.28	2.25	1.94	3.18
EPS, diluted	3.15	3.09	2.61	1.41	13.42	7.44	5.19	2.20	1.92	3.14
Shares, basic (weighted)	62.4	60.9	57.2	55	52.7	49.9	48.6	49.2	49.4	49.1
Shares, diluted (weighted)	64.9	63	58.8	56	53.9	51	49.4	50.3	50.1	49.7
Dividend per share	0.80	0.84	0.92	0.96	1.03	1.12	1.24	0.96	0.68	0.76

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	278	122	92.4	147	640	34.5	422	244	250	27.7
Receivables	487	573	502	341	640	857	225	200	216	228
Inventory	354	454	484	405	565	759	194	165	169	207
Other current assets	55.4	60.1	69.5	68.5	69	93.7	46.3	47.9	37.4	41.3
Total current assets	1,191	1,241	1,166	983	1,968	1,786	1,868	674	685	524
Property, plant and equipment	570	585	579	573	515	696	256	227	270	311
Lease right-of-use assets			0	31.6	35.1	98.8	24.7	18.7	22.7	42.9
Goodwill	248	345	335	321	351	321	336	332	376	501
Intangible assets	82.8	214	196	184	240	299	231	221	190	323
Other non-current assets	24.8	20.5	20.6	35	30.6	34.4	14.3	21.3	20.7	28.2
Total assets	2,325	2,622	2,511	2,332	3,373	3,643	3,651	1,639	1,695	1,848
Accounts payable	368	473	394	247	567	668	127	91.6	103	115
Accrued liabilities	41.6	96.5	78.2	64.7	138	118	46.8	42	43.9	41.7
Short-term debt	6.81	1.47	151	0.15	0.46	48.3	0.26
Total current liabilities	521	647	698	388	788	932	718	178	197	221
Long-term debt	572	749	598	700	710	696	690	298	303	306
Lease liabilities			0	25.8	27.4	88.2	18.3	12.8	17.2	35.9
Other non-current liabilities	61.5	74.2	70	75.8	82.8	116	71.8	62.2	53.4	56.7
Total liabilities	1,251	1,585	1,562	1,365	1,822	2,029	1,829	748	757	821
Total debt	579	750	749	700	710	747	695	299	304	307
Paid-in capital	303	296	283	284	283	273	291	299	309	312
Retained earnings	676	638	592	572	1,070	1,230	1,428	589	625	704
Other comprehensive income	-27.8	-14.6	-43.5	-35.2	45.4	-22.9	-23.2	0.45	4.05	10.9
Shareholders' equity	952	919	831	821	1,398	1,481	1,696	889	937	1,027
Minority interests	122	118	117	146	154	133	126	2.13	1.05	0
Total equity	1,074	1,036	948	966	1,552	1,614	1,822	891	938	1,027
Total liabilities and equity	2,325	2,622	2,511	2,332	3,373	3,643	3,651	1,639	1,695	1,848
Shares outstanding	62.8	58.9	55.5	54.6	51.3	48.4	48.7	49.5	49.2	48.7

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	218	201	163	84.4	741	399	269	118	95	155
Depreciation and amortization	86.8	103	95.6	92.7	87.7	98.8	113	80.7	48.3	57.3
Stock-based compensation	14.3	13.8	11.7	11.9	19.1	16.1	19.2	16.7	16.2	13.7
Deferred income tax	18.4	-38.2	17.4	-1.31	4.82	10.6	-7.08	3.04	-18.4	8.44
Change in receivables	-39.9	-53.1	73.3	147	-223	-151	143	50.1	-22.3	7.71
Change in inventory	-34.6	-84.7	-33.6	62.1	-170	-118	160	63.6	11.5	-11.6
Change in payables	67.5	83.1	-93.3	-143	315	12.2	-150	-65.4	0.62	3.82
Cash from operations	336	281	198	337	274	70.1	625	290	210	226
Capital expenditures	-68.4	-76.1	-84.5	-95.5	-82.2	-94.6	-86.4	-83.5	-50.6	-55.9
Acquisitions		-285	-10.4	-30.7	-130	-377	-56.1	-42	-95	-304
Sales and maturities of investments					634
Cash from investing	-63	-337	11.5	-116	469	-438	-71.8	-141	-135	-360
Debt issued		198
Debt repaid	-0.87	-31.1	-1.39	-155	-0.62	-0.57	-6.69	-394		-1.85
Share buybacks	0	-204	-168	-51	-192	-180			-30.9	-43.7
Dividends paid	-50.7	-51.4	-52.3	-53.3	-53	-57.2	-59.2	-56.8	-33.9	-36.9
Cash from financing	-78.8	-100	-239	-166	-250	-238	-133	-360	-68.8	-88.4
Net change in cash	194	-156	-29.6	54.8	493	-606	420	-211	5.85	-222
Free cash flow	267	205	113	241	192	-24.5	539	206	159	170
Interest paid	29.8	34.8	38.8	33	29.1	29.7	29.3	17.6	12	12.5
Income taxes paid	55.7	44.8	38.8	25.1	161	119	65.9	81.4	39.6	48.6

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $62.24 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	27.4%	Gross profit / revenue.
Operating margin	5.5%	Operating income / revenue.
EBITDA margin	9.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	14.6%	Pre-tax income / revenue.
Net margin	11.3%	Net income / revenue.
FCF margin	12.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	16.4%	Cash from operations / revenue.
Effective tax rate	23.0%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	15.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.8%	Net income / average total assets.
Return on invested capital (ROIC)	5.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	21.4%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.0%	Capital expenditures / revenue.
D&A / revenue	4.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	19.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-34.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-15.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	18.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	5.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-10.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y	36.7%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-14.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	255.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-2.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-12.2%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	62.5%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-15.3%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-26.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	63.5%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-15.4%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-25.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	7.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-28.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-3.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	6.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-31.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-2.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	11.8%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	-15.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	-5.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	9.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-15.4%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-6.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	9.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-20.3%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-11.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.8%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.6%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.37x	Current assets / current liabilities.
Quick ratio	1.16x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.13x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.30x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	16.6%	Total debt / total assets.
Liabilities / assets	44.4%	Total liabilities / total assets.
Net debt	$279.2M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.09x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	12.2x	Operating income / interest expense.
Working capital	$303.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	44.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$203.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.78x	Revenue / average total assets.
Fixed asset turnover	4.75x	Revenue / average property, plant and equipment.
Inventory turnover	5.33x	Cost of revenue / average inventory.
Days inventory	69 days	365 x average inventory / cost of revenue.
Receivables turnover	6.22x	Revenue / average receivables.
Days sales outstanding	59 days	365 x average receivables / revenue.
Days payables	40 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	87 days	Days inventory + days sales outstanding - days payables.
FCF conversion	109.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	24.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$3.14	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$3.18	Net income per basic share, as reported (split-adjusted).
Revenue per share	$27.78	Revenue / diluted weighted shares.
FCF per share	$3.42	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.55	Cash from operations / diluted weighted shares.
Book value per share	$21.10	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$4.18	Tangible book value / shares outstanding.
Cash per share	$0.57	(Cash + short-term investments) / shares outstanding.
Dividend per share	$0.76	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	23.6%	Dividends paid / net income, when net income is positive.
Dividends / FCF	21.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	25.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$3.05B	Share price x shares outstanding.
Enterprise value	$3.32B	Market cap + total debt - cash - short-term investments.
P/E	19.5x	Market cap / net income. Only when net income is positive.
P/S	2.20x	Market cap / revenue.
P/B	2.97x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	15.0x	Market cap / tangible book value, when positive.
P/FCF	17.9x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	13.5x	Market cap / cash from operations, when positive.
EV/Sales	2.41x	Enterprise value / revenue.
EV/EBIT	43.6x	Enterprise value / operating income, when both are positive.
EV/EBITDA	24.9x	Enterprise value / EBITDA, when both are positive.
EV/FCF	19.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.6%	Free cash flow / market cap.
Earnings yield	5.1%	Net income / market cap (the inverse of P/E).
Dividend yield	1.2%	Dividends paid over the period / market cap.
Shareholder yield	2.6%	(Dividends paid + share buybacks) / market cap.

What was WORTHINGTON ENTERPRISES, INC.'s revenue in fiscal 2026?

WORTHINGTON ENTERPRISES, INC. reported revenue of $1.38B for fiscal 2026, 19.7% higher than the year before.

Was WORTHINGTON ENTERPRISES, INC. profitable in fiscal 2026?

Yes. Net income was $156.1M, a net margin of 11.3%.

How much free cash flow did WORTHINGTON ENTERPRISES, INC. generate in fiscal 2026?

Cash from operations of $226.1M minus capital expenditures of $55.9M left free cash flow of $170.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to WORTHINGTON ENTERPRISES, INC.